Generic medicine

Bisoprolol Fumarate + Amlodipine Besilate: Brands, Price & Uses in Bangladesh

Bisoprolol Fumarate + Amlodipine Besilate is a fixed-dose combination antihypertensive indicated for the treatment of hypertension in adult patients who require combination therapy to achieve…

Forms:Tablet

About Bisoprolol Fumarate + Amlodipine Besilate

Indications of Bisoprolol Fumarate + Amlodipine Besilate

Bisoprolol Fumarate + Amlodipine Besilate is a fixed-dose combination antihypertensive indicated for the treatment of hypertension in adult patients who require combination therapy to achieve adequate blood pressure control.

Evidence-based classification of use

  • Established/guideline-supported use: Management of essential hypertension in patients not adequately controlled on a single antihypertensive agent, or as initial therapy in patients whose blood pressure is significantly above goal, where combination therapy with a beta-blocker and a calcium channel blocker is judged appropriate by the treating physician.
  • Combination-dependent use: Bisoprolol Fumarate + Amlodipine Besilate is intended for patients already established on, or determined to need, both a beta-1 selective blocker and a dihydropyridine calcium channel blocker; it is not intended as first-line monotherapy substitution without individualized assessment.
  • Adjunct benefit: In patients with hypertension and concomitant stable angina or certain arrhythmias requiring rate control, the beta-blocker component of Bisoprolol Fumarate + Amlodipine Besilate may provide additional symptomatic benefit, though this is not a primary approved indication for the fixed-dose product itself.

Bisoprolol Fumarate + Amlodipine Besilate is not indicated for hypertensive emergencies, initial therapy in treatment-naive patients without prior assessment of individual component response, or as a substitute for lifestyle modification.

Dosage & Administration of Bisoprolol Fumarate + Amlodipine Besilate

Hypertension (adults)

IndicationTypical starting doseTitration / maintenance
Essential hypertension requiring combination therapyLowest available strength of Bisoprolol Fumarate + Amlodipine Besilate once daily (e.g. bisoprolol 2.5 mg/amlodipine 5 mg equivalent, per locally marketed strengths)May be titrated to a higher fixed-dose strength after 2-4 weeks based on individual blood pressure response and tolerability, up to the maximum strength marketed locally

Renal impairment

Amlodipine pharmacokinetics are not significantly altered by renal impairment; bisoprolol is partly renally eliminated, so in patients with significant renal impairment, dose initiation with the lowest strength and careful monitoring is recommended before considering Bisoprolol Fumarate + Amlodipine Besilate, or the individual components may need to be titrated separately first.

Hepatic impairment

Amlodipine is extensively hepatically metabolized; in patients with hepatic impairment, slower titration and lower starting doses are recommended. Bisoprolol Fumarate + Amlodipine Besilate should be initiated cautiously, generally starting with the lowest available strength, in patients with hepatic impairment.

Side Effects of Bisoprolol Fumarate + Amlodipine Besilate

Side effects of Bisoprolol Fumarate + Amlodipine Besilate reflect the combined profiles of bisoprolol fumarate and amlodipine besilate.

  • Common: Peripheral (ankle) edema, fatigue, dizziness, headache, bradycardia, flushing, palpitations.
  • Less common: Cold extremities, gastrointestinal disturbance (nausea, abdominal discomfort), sleep disturbance, mood changes, hypotension, gingival hyperplasia.
  • Rare but important: Bronchospasm (particularly in patients with reactive airway disease), significant AV conduction disturbances, worsening heart failure, erectile dysfunction.

Peripheral edema from the amlodipine component is dose-related and a common reason patients discontinue Bisoprolol Fumarate + Amlodipine Besilate; fatigue, dizziness, and bradycardia relate mainly to the bisoprolol component and are most prominent at treatment initiation or after dose increases.

Contraindications of Bisoprolol Fumarate + Amlodipine Besilate

Bisoprolol Fumarate + Amlodipine Besilate is contraindicated in patients with any of the following:

  • Known hypersensitivity to bisoprolol, amlodipine, other dihydropyridine calcium channel blockers, or any component of the formulation.
  • Severe bradycardia.
  • Second- or third-degree atrioventricular (AV) block, in the absence of a functioning pacemaker.
  • Sick sinus syndrome.
  • Cardiogenic shock.
  • Decompensated heart failure.
  • Severe hypotension.
  • Severe peripheral arterial occlusive disease.

Frequently Asked Questions about Bisoprolol Fumarate + Amlodipine Besilate

What is Bisoprolol Fumarate + Amlodipine Besilate used for?

Bisoprolol Fumarate + Amlodipine Besilate is a fixed-dose combination medicine used to treat high blood pressure (hypertension) in adults who need both a beta-blocker and a calcium channel blocker to keep their blood pressure controlled.

How should I take Bisoprolol Fumarate + Amlodipine Besilate?

Bisoprolol Fumarate + Amlodipine Besilate is usually taken once daily, at around the same time each day, with or without food. Swallow the tablet whole with water; do not crush or chew it unless your physician tells you to.

Can I stop taking Bisoprolol Fumarate + Amlodipine Besilate suddenly if I feel better?

No. You should never stop Bisoprolol Fumarate + Amlodipine Besilate abruptly, because the beta-blocker component can cause rebound high blood pressure, chest pain, or an abnormal heart rhythm if stopped suddenly. Always ask your physician how to taper off the dose gradually if treatment needs to be stopped.

What are the most common side effects of Bisoprolol Fumarate + Amlodipine Besilate?

The most common side effects of Bisoprolol Fumarate + Amlodipine Besilate include swelling of the ankles or feet, tiredness, dizziness, slow heart rate, headache, and flushing. Swelling and dizziness are often more noticeable when treatment is first started or after a dose increase.

Is Bisoprolol Fumarate + Amlodipine Besilate safe during pregnancy or breastfeeding?

Bisoprolol Fumarate + Amlodipine Besilate should be used in pregnancy or while breastfeeding only if a physician determines it is clearly needed, since both components can affect the fetus or nursing infant. Always consult your physician before taking Bisoprolol Fumarate + Amlodipine Besilate if you are pregnant, planning pregnancy, or breastfeeding.

Who should not take Bisoprolol Fumarate + Amlodipine Besilate?

Bisoprolol Fumarate + Amlodipine Besilate should not be used by people with severe slow heart rate, certain heart block conditions without a pacemaker, sick sinus syndrome, cardiogenic shock, decompensated heart failure, severe low blood pressure, severe peripheral artery disease, or known allergy to bisoprolol, amlodipine, or similar drugs. Discuss your full medical history with your physician before starting Bisoprolol Fumarate + Amlodipine Besilate.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles